Retrieve available abstracts of 62 articles: HTML format
Single Articles
June 2025
DUBBELMAN MA, Liu A, Donohue MC, Langford O, et al Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired
Older Adults With and Without Elevated Amyloid.
Neurology. 2025;104:e213775. PubMedAbstract available
GONZALEZ-ORTIZ F, Kirsebom BE, Yakoub Y, Gundersen JK, et al Associations Between Changes in Levels of Phosphorylated Tau and Severity of
Cognitive Impairment in Early Alzheimer Disease.
Neurology. 2025;104:e213676. PubMedAbstract available
MENDES AJ, Ribaldi F, Pievani M, Boccalini C, et al Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's
Association Workgroup 2024 for Alzheimer Disease.
Neurology. 2025;104:e213675. PubMedAbstract available
May 2025
MUJANOVIC A, Yogendrakumar V, Ng FC, Gattringer T, et al Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy:
Target Trial Emulation.
Neurology. 2025;104:e213641. PubMedAbstract available
OURRY V, Fajardo-Valdez A, Soucy JP, Poirier J, et al Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental
History of Alzheimer Disease: Role of Sex and Parent's Sex.
Neurology. 2025;104:e213507. PubMedAbstract available
April 2025
BONOMI CG, Martorana A, Motta C, Serafini C, et al Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its
Relationship With Nigrostriatal Denervation.
Neurology. 2025;104:e213463. PubMedAbstract available
DEMEESTERE J, Verhaaren BFJ, Christensen S, Wouters A, et al Underestimation of Follow-Up Infarct Volume by Acute CT Perfusion Imaging.
Neurology. 2025;104:e213439. PubMedAbstract available
March 2025
TURPIN AL, Felisatti F, Chauveau L, Haudry S, et al Association Between Lifestyle at Different Life Periods and Brain Integrity in
Older Adults.
Neurology. 2025;104:e213347. PubMedAbstract available
LI XY, Tang G, Lu J, Zhao Y, et al Self-Reported REM Sleep Behavior Disorder in Patients With Progressive
Supranuclear Palsy: Clinical and (18)F-Florzolotau PET Imaging Findings.
Neurology. 2025;104:e213376. PubMedAbstract available
PALERMO G, Francesconi A, Bellini G, Morganti R, et al Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal
Pressure Hydrocephalus and Parkinsonism.
Neurology. 2025;104:e213352. PubMedAbstract available
February 2025
LIANG J, Hussainy S, Lee SM, Wu G, et al Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease
Progression, Biomarkers, and Amyloid Deposition.
Neurology. 2025;104:e210250. PubMedAbstract available
BORNHORST JA, Lundgreen CS, Weigand SD, Figdore DJ, et al Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma
P-Tau217 Concentrations.
Neurology. 2025;104:e210287. PubMedAbstract available
JOUTSA J, Rinne JO, Niemi KJ, Karrasch M, et al Progression of Amyloid Accumulation in Late Adulthood Among People With
Childhood-Onset Epilepsy.
Neurology. 2025;104:e210303. PubMedAbstract available
GARCIA-ESPERON C, Berry-Noronha A, Di Bartolo A, Green DS, et al Arterial Input Function Dispersal on Acute Brain CT Perfusion Scan in Patients
With Acute Stroke and an Intracardiac Thrombus.
Neurology. 2025;104:e210256. PubMedAbstract available
January 2025
QUISPIALAYA KM, Therriault J, Aliaga A, Benedet AL, et al Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer
Disease in People With Early-Onset or Atypical Dementia.
Neurology. 2025;104:e210211. PubMedAbstract available
RODRIGUEZ-BAZ I, Benejam B, Morcillo-Nieto AO, Vaque-Alcazar L, et al Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down
Syndrome: A Case Report.
Neurology. 2025;104:e210179. PubMedAbstract available
CHEN Z, Jiang D, Kong Y, Zhang J, et al Association of Glymphatic Function With Clinical Characteristics in Patients With
Clinical and Asymptomatic Creutzfeldt-Jakob Disease.
Neurology. 2025;104:e210055. PubMedAbstract available
December 2024
YOO HS, Lee YG, Sohn YH, Yun M, et al Association of Relative Brain Hyperperfusion Independent of Dopamine Depletion
With Motor Dysfunction in Patients With Parkinson Disease.
Neurology. 2024;103:e210077. PubMedAbstract available
YOO HS, Kim HK, Na HK, Kang S, et al Association of Striatal Dopamine Depletion and Brain Metabolism Changes With
Motor and Cognitive Deficits in Patients With Parkinson Disease.
Neurology. 2024;103:e210105. PubMedAbstract available
BOCCALINI C, Dodich A, Scheffler M, Lagana V, et al In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1
Met146Leu Pathogenic Variant.
Neurology. 2024;103:e210103. PubMedAbstract available
BISCHOF GN, Jaeger E, Giehl K, Jessen F, et al Cortical Tau Aggregation Patterns Associated With Apraxia in Patients With
Alzheimer Disease.
Neurology. 2024;103:e210062. PubMedAbstract available
VELLIEUX G, Apartis E, Baudin P, Del Rio Quinones MA, et al Multimodal Assessment of the Origin of Myoclonus in Lance-Adams Syndrome.
Neurology. 2024;103:e209994. PubMedAbstract available
November 2024
PENSATO U, Bosshart S, Stebner A, Rohr A, et al Effect of Hemoglobin and Blood Glucose Levels on CT Perfusion Ischemic Core
Estimation: A Post Hoc Analysis of the ESCAPE-NA1 Trial.
Neurology. 2024;103:e209939. PubMedAbstract available
MICHAELSON NM, Klawiter EC, Singhal T Journal Club: PET Imaging in Multiple Sclerosis and Its Prognostic Implications.
Neurology. 2024;103:e210047. PubMed
LAM AD, Thibault EG, Mayblyum DV, Hsieh S, et al Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain
Atrophy in Patients With Alzheimer Disease and Seizures.
Neurology. 2024;103:e209920. PubMedAbstract available
HAZAN J, Liu KY, Costello H, Isaacs JD, et al Challenges in a Biological Definition of Alzheimer Disease.
Neurology. 2024;103:e209884. PubMedAbstract available
WATANABE H, Duffy JR, Clark H, Machulda MM, et al Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic
Variants: Clinical, Neuroimaging, and Neuropathologic Features.
Neurology. 2024;103:e209924. PubMedAbstract available
August 2024
ROMOLI M, Marinoni G, Tagliabue L, Capozza A, et al (18F)Flutemetamol-PET Aided Classification of Cerebral Amyloid Angiopathy: A
Multicenter Study.
Neurology. 2024;103:e209719. PubMedAbstract available
VAN DER VEERE PJ, Hoogland J, Visser LNC, Van Harten AC, et al Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive
Impairment or Mild Dementia.
Neurology. 2024;103:e209605. PubMedAbstract available
NISHIDA A, Shima A, Kambe D, Furukawa K, et al Frontoparietal-Striatal Network and Nucleus Basalis Modulation in Patients With
Parkinson Disease and Gait Disturbance.
Neurology. 2024;103:e209606. PubMedAbstract available
WANG J, Ackley S, Woodworth DC, Sajjadi SA, et al Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal
Volume With Cognitive Trajectories in the 90+ Study.
Neurology. 2024;103:e209665. PubMedAbstract available
July 2024
MUJANOVIC A, Ng FC, Branca M, Deutschmann HA, et al External Validation of a Model for Persistent Perfusion Deficit in Patients With
Incomplete Reperfusion After Thrombectomy: EXTEND-PROCEED.
Neurology. 2024;103:e209401. PubMedAbstract available
OH Y, Kim JS, Lyoo CH, Park G, et al Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter
Volume in Parkinson Disease-Related Cognitive Impairment.
Neurology. 2024;103:e209498. PubMedAbstract available
XIA Y, Dore V, Fripp J, Bourgeat P, et al Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer
Disease.
Neurology. 2024;103:e209626. PubMedAbstract available
MASTENBROEK SE, Sala A, Vallez Garcia D, Shekari M, et al Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease
Heterogeneity.
Neurology. 2024;103:e209419. PubMedAbstract available
June 2024
BABULAL GM, Chen L, Murphy SA, Carr DB, et al Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of
Alzheimer Disease Biomarkers and Clinical Assessments.
Neurology. 2024;102:e209426. PubMedAbstract available
YE R, Goodheart AE, Locascio JJ, Peterec E, et al Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition
in the Lewy Body Diseases.
Neurology. 2024;102:e209460. PubMedAbstract available
JADICK MF, Robinson T, Farrell ME, Klinger H, et al Associations Between Self and Study Partner Report of Cognitive Decline With
Regional Tau in a Multicohort Study.
Neurology. 2024;102:e209447. PubMedAbstract available
DI LUCA DG, Perlmutter JS Time for Clinical Dopamine Transporter Scans in Parkinsonism?: Not DAT Yet.
Neurology. 2024;102:e209558. PubMed
HASTINGS A, Cullinane P, Wrigley S, Revesz T, et al Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic
Imaging in the Diagnosis of Parkinsonism.
Neurology. 2024;102:e209453. PubMedAbstract available
May 2024
RUS T, Cuderman A, Georgiev D Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of
Presynaptic Dopaminergic Imaging.
Neurology. 2024;102:e209384. PubMed
COURTNEY MR, Antonic-Baker A, Chen Z, Sinclair B, et al Association of Localizing (18)F-FDG-PET Hypometabolism and Outcome Following
Epilepsy Surgery: Systematic Review and Meta-Analysis.
Neurology. 2024;102:e209304. PubMedAbstract available
BARATEAU L, Krache A, Da Costa A, Lecendreux M, et al Microglia Density and Its Association With Disease Duration, Severity, and Orexin
Levels in Patients With Narcolepsy Type 1.
Neurology. 2024;102:e209326. PubMedAbstract available
April 2024
WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid
and Tau Burden 15 Years Later in Dementia-Free Adults.
Neurology. 2024;102:e209198. PubMedAbstract available
CAI Y, Shi D, Lan G, Chen L, et al Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and
Metabolism in Older Adults Without Dementia.
Neurology. 2024;102:e209205. PubMedAbstract available
GREENBERG S, Battioui C, Lu M, Biffi A, et al ARIA Insights from the Donanemab Trials (P1-9.001).
Neurology. 2024;102. PubMedAbstract available
APPLETON J, Funk Q, Fregonara PZ, Yu M, et al Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from
Early Onset Alzheimer's Disease (N4.002).
Neurology. 2024;102. PubMedAbstract available
March 2024
HONIG M, Altomare D, Caprioglio C, Collij L, et al Association Between Years of Education and Amyloid Burden in Patients With
Subjective Cognitive Decline, MCI, and Alzheimer Disease.
Neurology. 2024;102:e208053. PubMedAbstract available
ACKLEY S, Calmasini C, Bouteloup V, Hill-Jarrett TG, et al Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the
MEMENTO Cohort.
Neurology. 2024;102:e208054. PubMedAbstract available
February 2024
RAHAYEL S, Postuma R, Baril AA, Misic B, et al (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in
Patients With Isolated REM Sleep Behavior Disorder.
Neurology. 2024;102:e208015. PubMedAbstract available
January 2024
PALLEIS C, Franzmeier N, Weidinger E, Bernhardt AM, et al Association of Neurofilament Light Chain, [(18)F]PI-2620 Tau-PET, TSPO-PET, and
Clinical Progression in Patients With beta-Amyloid-Negative CBS.
Neurology. 2024;102:e207901. PubMedAbstract available
December 2023
HANSEEUW BJ, Jacobs HIL, Schultz AP, Buckley RF, et al Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline
in Clinically Normal Adults.
Neurology. 2023;101:e2533-e2544. PubMedAbstract available
November 2023
YOON SH, Kim HK, Lee JH, Chun JH, et al Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical
Atrophy, and Cognitive Dysfunction Across the AD Continuum.
Neurology. 2023;101:e2162-e2171. PubMedAbstract available
October 2023
THEIS H, Bischof GN, Bruggemann N, Dargvainiene J, et al In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using (18)F-PI-2620
PET.
Neurology. 2023 Oct 25:10.1212/WNL.0000000000207870. PubMedAbstract available
BEAUCHAMP LC, Dore V, Villemagne VL, Xu S, et al Utilizing (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal
Degeneration in Parkinson Disease.
Neurology. 2023 Oct 10:10.1212/WNL.0000000000207748. PubMedAbstract available
September 2023
COOMANS EM, de Koning LA, Rikken RM, Verfaillie SC, et al Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer
Disease Continuum and in Dementia With Lewy Bodies.
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207794. PubMedAbstract available
CHEVAL M, Rodrigo S, Leroy C, Taussig D, et al [(18)F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With
Drug-Resistant Focal Epilepsy.
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207811. PubMedAbstract available
MALPETTI M, Rabinovici GD From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis
and Patient Stratification.
Neurology. 2023 Sep 25:10.1212/WNL.0000000000207935. PubMed
July 2023
DURCAN R, Roberts G, Hamilton CA, Donaghy PC, et al Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy
Bodies, Alzheimer Disease, and Age-Matched Controls.
Neurology. 2023 Jul 31:10.1212/WNL.0000000000207621. PubMedAbstract available
PROKOPIOU PC, Engels-Dominguez N, Schultz AP, Sepulcre J, et al Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau
Deposition and Memory Decline in Preclinical Alzheimer Disease.
Neurology. 2023 Jul 25:10.1212/WNL.0000000000207646. PubMedAbstract available
October 2022
CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al Association Between White Matter Networks and the Pattern of Striatal Dopamine
Depletion in Patients With Parkinson Disease.
Neurology. 2022 Oct 4. pii: WNL.0000000000201269. PubMedAbstract available
September 2022
KAMAGATA K, Andica C, Takabayashi K, Saito Y, et al Association of MRI Indices of Glymphatic System With Amyloid Deposition and
Cognition in Mild Cognitive Impairment and Alzheimer Disease.
Neurology. 2022 Sep 19. pii: WNL.0000000000201300. PubMedAbstract available